Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RareChannels is a specialized B2B marketing and resource platform dedicated to the rare disease sector. Founded by Carol J. Dickerson, PharmD, the company connects rare disease drug manufacturers with a network of 'Partners in Rare' (PIRs)—vetted service providers specializing in areas such as clinical trials, manufacturing, logistics, and market access. The platform aims to reduce the time and cost of bringing orphan drugs to market by providing a centralized, searchable directory of niche experts who understand the unique challenges of small patient populations. Through its digital hub, RareChannels facilitates strategic collaborations that streamline the commercialization and distribution of orphan therapies globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RareChannels.